Analyst firms · Jefferies · AGL
Jefferies AGL price target and rating history
agilon health inc. (AGL) · Health Care
Jefferies rates agilon health inc. (AGL) Buy with a $48 price target, as of its latest action on May 7, 2026. It has published 3 rating actions on AGL since October 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Jefferies's $48 is 41% below that.
- Current rating
- Buy
- Price target
- $48
- Median target, all firms
- $81
- Actions on AGL
- 3
Jefferies price target on AGL
Every Jefferies rating on AGL
- May 7, 2026
- Feb 26, 2024
- Oct 20, 2021
How other firms rate AGL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Outperform | $125 | Sep 15, 2026 |
| Citigroup | Neutral | $115 | Aug 11, 2026 |
| Barclays | Equal Weight | $81 | May 26, 2026 |
| Jefferies | Buy | $48 | May 7, 2026 |
| Deutsche Bank | Buy | $49 | May 7, 2026 |
Questions about Jefferies and AGL
- What is Jefferies's price target for AGL?
- Jefferies's latest stated price target for agilon health inc. (AGL) is $48, from its action on May 7, 2026.
- What is Jefferies's rating on AGL?
- Jefferies rates AGL Buy, a bullish rating, as of May 7, 2026.
- When did Jefferies last change its view on AGL?
- On May 7, 2026, Jefferies upgrades to Buy from Hold, price target $48.
- How does Jefferies's AGL target compare with other analysts?
- Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Jefferies's $48 is 41% below that.
More AGL rating histories
All Jefferies ratingsAGL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.